ProfileGDS4459 / ENSG00000177192
TitleIntraportal tacrolimus flushing effect on liver allograft
OrganismHomo sapiens


flushed with tacrolimus flushed with albumin control GSM623464 GSM623465 GSM623466 GSM623467 GSM623468 GSM623469 GSM623470 GSM623471 GSM623472 GSM623473 GSM623474 GSM623475 GSM623476 GSM623477 GSM623478 GSM623479 GSM623480 59% 37% 52% 37% 40% 47% 56% 39% 46% 56% 25% 44% 45% 65% 48% 45% 61% sort by protocol Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM623464group A, liver allograft wedge biopsie tacrolimus treatment 14.7459
GSM623465group A, liver allograft wedge biopsie tacrolimus treatment 23.9937
GSM623466group A, liver allograft wedge biopsie tacrolimus treatment 34.4452
GSM623467group A, liver allograft wedge biopsie tacrolimus treatment 44.0937
GSM623468group A, liver allograft wedge biopsie tacrolimus treatment 54.0240
GSM623469group A, liver allograft wedge biopsie tacrolimus treatment 64.347
GSM623470group A, liver allograft wedge biopsie tacrolimus treatment 74.6956
GSM623471group A, liver allograft wedge biopsie tacrolimus treatment 83.9439
GSM623472group A, liver allograft wedge biopsie tacrolimus treatment 94.2246
GSM623473group A, liver allograft wedge biopsie tacrolimus treatment 104.6756
GSM623474group B, liver allograft wedge biopsie placebo treatment 13.4125
GSM623475group B, liver allograft wedge biopsie placebo treatment 24.1244
GSM623476group B, liver allograft wedge biopsie placebo treatment 34.2245
GSM623477group B, liver allograft wedge biopsie placebo treatment 44.9565
GSM623478group B, liver allograft wedge biopsie placebo treatment 54.348
GSM623479group B, liver allograft wedge biopsie placebo treatment 64.2545
GSM623480group B, liver allograft wedge biopsie placebo treatment 74.7961